2015 ICD-9-CM Diagnosis Code 205.0
Myeloid leukemia acute
- There are 3 ICD-9-CM codes below 205.0 that define this diagnosis in greater detail. Do not use this code on a reimbursement claim.
Clinical Information
- A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (amls) encompasses four major categories: 1) aml with recurrent genetic abnormalities 2) aml with multilineage dysplasia 3) therapy-related aml 4) aml not otherwise categorized. The required bone marrow or peripheral blood blast percentage for the diagnosis of aml has been recently reduced from 30% (french-american-british [fab] classification) to 20% (who classification). (who, 2001)
- A quickly progressing disease in which too many immature blood-forming cells are found in the blood and bone marrow
- A type of acute myeloid leukemia, a quickly progressing disease in which too many immature blood-forming cells are found in the blood and bone marrow
- Acute leukemia arising from myeloid tissue in which the granular, polymorphonuclear leukocytes and their precursors predominate
- An acute myeloid leukemia (aml) in which abnormal promyelocytes predominate. It is characterized by the t(15;17)(q22;q12) translocation. There are two variants: the typical and micro granular (hypo granular) variant. This aml is particularly sensitive to treatment with all trans-retinoic acid and has a favorable prognosis. (who, 2001)
- Leukemia commonly occurring after alkylating agent treatment; manifestations include pancytopenia, megaloblastic bone marrow, and nucleated red cells in peripheral marrow; patients usually have chromosomal abnormalities in marrow cells
205.0 Excludes
- acute exacerbation of chronic myeloid leukemia (205.1
)
Applies To
- Acute promyelocytic leukemia
blastic (M9801/3) 208.0
granulocytic (M9861/3) 205.0
